BioAtla, Inc.BCABNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q3 2025 | -15.49% |
| Q2 2025 | -5.63% |
| Q1 2025 | 14.48% |
| Q4 2024 | -21.80% |
| Q3 2024 | 5.95% |
| Q2 2024 | 3.36% |
| Q1 2024 | -2.35% |
| Q4 2023 | -17.01% |
| Q3 2023 | 6.07% |
| Q2 2023 | -13.71% |
| Q1 2023 | 8.18% |
| Q4 2022 | 5.46% |
| Q3 2022 | -24.02% |
| Q2 2022 | 12.41% |
| Q1 2022 | 10.36% |
| Q4 2021 | -0.53% |
| Q3 2021 | -57.36% |
| Q2 2021 | 89.40% |
| Q1 2021 | 40.27% |
| Q4 2020 | 80.85% |
| Q3 2020 | 84.72% |
| Q2 2020 | 485.96% |
| Q1 2020 | -35.38% |
| Q4 2019 | 0.00% |